AI shows promise for predicting embryonic health without invasive testing

Researchers evaluate the effectiveness of artificial intelligence algorithms in non-invasively predicting embryonic ploidy from embryonic images.

Big Pharma Steps Onto the Psychedelics Wagon | Psychedelic Spotlight

Big Pharma has certainly taken note of the potential therapeutic benefits of psychedelics. Otsuka, a major Japanese Pharmaceutical company, recently signed an agreement to acquire

September 1, 2023

Fixing the reimbursement and coverage divide between ‘breakthrough’ drugs and medical devices

The Food and Drug Administration designates as “breakthrough” technologies certain drugs and devices. This designation helps expedite the development and review of therapies intended to

July 23, 2024

Highmark Grants Commercial Coverage to Theranica’s Wearable for Migraine Treatment

Nerivio is indicated for dual-use in people 12 years and older What You Should Know: – Theranica, a leader in neuromodulation devices for migraine and

February 21, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.